Table 5.
The structural characteristics of the cited-reference clusters.
| Cluster ID | Size | Silhouette | Mean (year) | Cluster name (LLR) |
|---|---|---|---|---|
| #0 | 28 | 0.559 | 2015 | Gut (6.13) |
| #1 | 20 | 0.753 | 2018 | Antibiotics (11.02) |
| #2 | 16 | 0.705 | 2015 | Biomarker (8.16) |
| #3 | 16 | 0.613 | 2016 | Carcinogenesis (6.37) |
| #4 | 14 | 0.754 | 2016 | Bronchopulmonary dysplasia (4.90) |
| #5 | 10 | 0.815 | 2013 | Fibrosis (7.23) |
| #6 | 9 | 0.920 | 2013 | host genetics (5.89) |
| #7 | 9 | 0.908 | 2013 | Immune-related adverse events (7.43) |
| #8 | 7 | 0.848 | 2018 | Neoadjuvant (4.34) |
LLR, log-likelihood ratio.